These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8813297)

  • 1. The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction.
    Casademont J; Barrientos A; Grau JM; Pedrol E; Estivill X; Urbano-Márquez A; Nunes V
    Brain; 1996 Aug; 119 ( Pt 4)():1357-64. PubMed ID: 8813297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.
    Arnaudo E; Dalakas M; Shanske S; Moraes CT; DiMauro S; Schon EA
    Lancet; 1991 Mar; 337(8740):508-10. PubMed ID: 1671889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
    Morgello S; Wolfe D; Godfrey E; Feinstein R; Tagliati M; Simpson DM
    Acta Neuropathol; 1995; 90(4):366-74. PubMed ID: 8546027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
    Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M
    Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
    Feeney ER; van Vonderen MG; Wit F; Danner SA; van Agtmael MA; Villarroya F; Domingo P; Capeau J; Reiss P; Mallon PW;
    AIDS; 2012 Nov; 26(17):2165-74. PubMed ID: 22874517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes.
    Cazzalini O; Lazzè MC; Iamele L; Stivala LA; Bianchi L; Vaghi P; Cornaglia A; Calligaro A; Curti D; Alessandrini A; Prosperi E; Vannini V
    Biochem Pharmacol; 2001 Oct; 62(7):893-902. PubMed ID: 11543724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy.
    Rosenfeldt FL; Mijch A; McCrystal G; Sweeney C; Pepe S; Nicholls M; Dennett X
    Int J STD AIDS; 2005 Dec; 16(12):827-9. PubMed ID: 16336769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.
    Cupler EJ; Danon MJ; Jay C; Hench K; Ropka M; Dalakas MC
    Acta Neuropathol; 1995; 90(1):1-6. PubMed ID: 7572071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zidovudine (AZT) on the structure and function of rat skeletal muscle.
    Engbretson BG
    Can J Physiol Pharmacol; 1996 Jun; 74(6):679-86. PubMed ID: 8909779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.
    Chariot P; Drogou I; de Lacroix-Szmania I; Eliezer-Vanerot MC; Chazaud B; Lombès A; Schaeffer A; Zafrani ES
    J Hepatol; 1999 Jan; 30(1):156-60. PubMed ID: 9927163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells.
    Wallace ZR; Sanderson S; Simon AK; Dorrell L
    Antiviral Res; 2016 Sep; 133():178-82. PubMed ID: 27496003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
    Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV detection in culture of peripheral blood mononuclear cells: a relevant in vitro correlate of the antiviral effect of ZDV in vivo.
    Escaich S; Ritter J; Rougier P; Bizollon T; Lepot D; Lamelin JP; Sepetjan M; Trepo C
    J Acquir Immune Defic Syndr (1988); 1992; 5(8):829-34. PubMed ID: 1517968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study.
    Calza L; Danese I; Colangeli V; Vandi G; Manfredi R; Girometti N; Borderi M; Appolloni L; Puggioli C; Viale P
    AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1162-9. PubMed ID: 25369244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G; Illa I; Dalakas MC
    Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.
    Ntemgwa M; Wainberg MA; Oliveira M; Moisi D; Lalonde R; Micheli V; Brenner BG
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3861-9. PubMed ID: 17724152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.